UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 82 filers reported holding UROGEN PHARMA LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $195,104,000 | -8.4% | 22,400 | 0.0% | 0.00% | – |
| Q4 2021 | $213,024,000 | -43.5% | 22,400 | 0.0% | 0.00% | – |
| Q3 2021 | $376,768,000 | +10.2% | 22,400 | 0.0% | 0.00% | – |
| Q2 2021 | $342,048,000 | -21.6% | 22,400 | 0.0% | 0.00% | – |
| Q1 2021 | $436,352,000 | +8.1% | 22,400 | 0.0% | 0.00% | – |
| Q4 2020 | $403,648,000 | -6.6% | 22,400 | 0.0% | 0.00% | – |
| Q3 2020 | $432,096,000 | -13.4% | 22,400 | +17.3% | 0.00% | – |
| Q2 2020 | $498,918,000 | +28.3% | 19,101 | -12.4% | 0.00% | – |
| Q1 2020 | $388,930,000 | -28.9% | 21,801 | +32.9% | 0.00% | – |
| Q4 2019 | $547,301,000 | +149.6% | 16,401 | +168.9% | 0.00% | – |
| Q2 2019 | $219,234,000 | -2.7% | 6,100 | 0.0% | 0.00% | – |
| Q1 2019 | $225,334,000 | – | 6,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |